To evaluate the efficacy of Kalmegh Navayas Tablet in the management of Anemia.
Phase 2
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2023/03/050929
- Lead Sponsor
- Dr. Poonam Agrawal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Hb level 7 to 10.8 gm/dl.
Patients having sign & symptoms of Pandu Roga like Agnimandya, Daurbalya, Aruchi, Twaka vaivarnata, Shoth bhram, Gatrashool ,Shwas kashtata.
Exclusion Criteria
a) Pregnant and lactating women.
b) Patients with K/C/O Thalassemia, Hereditary
Sickle Cell Anemia, Sideroblastic Anemia,
Anemia due to any Malignancies, Congenital
absence of Iron Binding Protein, Aplastic
Anemia, Haemolytic Anemia, etc.
c) Patients with menorrhage, metrorrhagia,
worm infestation and other bleeding disorders.
d) Patients with acute complications like cirrhosis
of liver, pancreatitis and Hypoglycemic shock.
e) Pandu vyadhi associated with other vyadhi like
kamla, halimak.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To increase the haemoglobin level in Pandu Roga (Anemia).Timepoint: Follow up of patients on 15 th and 30 th day.
- Secondary Outcome Measures
Name Time Method To observe the adverse effect, if any.Timepoint: Follow up of patients on 15 th and 30 th day.